Book Value per Share: Zura Bio (ZURA)
Zura Bio Limited (ZURA) operations in developing anti-inflammatory agents are completely autonomous from economic cycles and seasonal factors. A team of top specialists is developing therapies for autoimmune pathologies utilizing the company's advanced resources. This price chart reflects market performance, where the current value stands at 2.06. The business model is based on the active engagement of third-party laboratories for the primary testing of new molecules.
zurabio.com - analytical breakdowns and key metrics (ZURA)
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
Fundamental company valuation:Zura Bio Limited - ZURA
For an investor in Zura Bio Limited (ZURA), the fundamental value of assets serves as a key measure of financial stability within the biotechnology sector. This metric reflects the difference between all company assets and liabilities divided by the number of shares, while information on the book value per share helps assess the risk of capital impairment resulting from reagent supply disruptions or complexities regarding international patent protection.
Competitors of Zura Bio Limited (ZURA)
Net Assets per Single Share Argenx (ARGX)|BNTX - Accounting Value of a Share|ABVX: Book Value per Share|ADMA (admabiologics.com) - Book Value per Share|Net Assets per Single Share Protagonist PTGX|Share Book Value Immunovant Inc|Kiniksa Pharmaceuticals Ltd (KNSA) - Book Value per Share|Accounting Value of a Share Grifols Biemat (GRFS)|Book Value per Share ADPT (Adaptive Biotechnologies)|celldex.com - Book Value per Share|Net Assets per Single Share Aurinia Pharmaceuticals Inc. (AUPH)|BCRX: Accounting Value of a Share|VERA (Vera Pharma) - Net Assets per Single Share|Dianthus Corp (DNTH) - Accounting Value per Share|PHVS (Pharvaris N.V.) - Book Value per Share|Book Value per Share AbCellera Corp (ABCL)|Tourmaline Bio (TRML) - Accounting Value per Share|Accounting Value of a Share Precigen Inc (PGEN)|Book Value per Share PHAR|Nektar Corp - Net Assets per Share|UPB: Net Assets per Single Share|ZBIO: Accounting Value per Share|IMNM (Immunome) - Net Assets per Single Share|Accounting Value per Share Gossamer Bio Inc|KALV (KalVista Pharmaceuticals Inc) - Accounting Value per Share|Book Value per Share SEPN|Net Assets per Single Share Pieris Pharmaceuticals PVLA|Equity per Share savarapharma.com (SVRA)|RIGL: Book Value per Share|ANAB - Net Asset Value per Share|Accounting Value per Share Astria Pharma|enGene Corp (ENGN) - Share Book Value|RAPT: Accounting Value per Share|JBIO (Aerovate Therapeutics) - Book Value per Share|ACRS - Net Assets per Single Share|Accounting Value of a Share Kyverna Therapeutics Inc.|Book Value per Share TLSA|Book Value per Share Cabaletta Bio Inc CABA|Accounting Value per Share Ventyx Biosciences|Accounting Value of a Share theratech.com THTX|AVTX - Book Value per Share|ELDN - Net Assets per Single Share|Agenus Inc - Book Value per Share|CLYM (Climb Bio, Inc) - Net Assets per Share|Net Assets per Single Share ATYR (aTyr Pharma, Inc.)|Net Asset Value per Share Adagene Corp (ADAG)|ImageneBio Inc (IMA) - Accounting Value per Share|Accounting Value of a Share STTK (shattucklabs.com)|Net Assets per Single Share Equillium EQ|Net Assets per Single Share Connect Biopharma Holdings CNTB|Book Value per Share IMUX (Immunic Inc)|ATRA: Net Assets per Share|IFRX (inflarx.de) - Net Assets per Single Share|X4 Pharmaceuticals Inc. (XFOR) - Accounting Value per Share|ACET: Book Value per Share|Net Assets per Share Celularity Corp (CELU)|Accounting Value per Share INmune Bio, Inc.|Book Price of a Share barinthusbio.com (BRNS)|KZR: Book Value per Share|Net Asset Value per Share SAB Biotherapeutics Inc. SABS|Akari Therapeutics plc (AKTX) - Book Value per Share|Enlivex Therapeutics (ENLV) - Equity per Share|Accounting Value per Share q32bio.com (QTTB)|Share Book Value geovax.com|EDSA (Edesa Biotech) - Accounting Value per Share|Book Value per Share IBIO|Carisma Therapeutics (CARM) - Net Assets per Single Share|Accounting Value of a Share XTL Bio (XTLB)|Book Value per Share BOLT (Bolt Biotherapeutics, Inc.)|HCW Biologics, Inc. - Book Value per Share|Net Assets per Single Share Aptevo|AIM - Share Book Value|Book Value per Share aditxt.com ADTX|GRI Bio Corporation (GRI) - Accounting Value of a Share|XRTX (XORTX Therapeutics Inc.) - Book Value per Share|Book Value per Share HIND|Revelation Biosciences, Inc. (REVB) - Net Assets per Single Share|Accounting Value of a Share INDP (Indaptus Therapeutics Inc)|Scinai - Net Assets per Single Share|Accounting Value per Share CalciMedica Inc CALI|Affimed Therapeutics - Book Value per Share|Allakos Inc. (ALLK) - Book Value per Share|Accounting Value per Share hookipapharma.com HOOK|IGM Biosciences (IGMS) - Accounting Value of a Share|ITOS: Book Value per Share|Net Assets per Share OCEA|Net Assets per Single Share TCBP (TC Biopharm)|Accounting Value per Share THRD (thirdharmonicbio.com)